Biotech · Private company · Boulder, CO, US
Crestone, Inc
Track this companyFree. Adds Crestone, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Active ComparatorPhase 2 · Clostridioides Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CRS3123Phase 2 · Clostridioides Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CRS3123 200 mg capsulePhase 1 · Food Effect in Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Apr 21, 2025ClinicalTrials.gov NCT06988423 · fetched Nov 12, 2026
- Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile InfectionPHASE2 · COMPLETED · started Jan 5, 2021ClinicalTrials.gov NCT04781387 · fetched Nov 12, 2026
NIH awards6
- Development of Therapeutic Products for Antibacterial Resistant Infections Fiscal year 2026 · $1.4MNIH RePORTER 75N93019C00056-P00016-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Antibiotic Resistant BacteriaFiscal year 2026 · $3.5MNIH RePORTER 75N93020C00020-P00014-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Antibacterial Resistant Infections Fiscal year 2025 · $3.9MNIH RePORTER 75N93019C00056-P00013-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Antibiotic Resistant BacteriaFiscal year 2025 · $1.6MNIH RePORTER 75N93020C00020-P00010-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious DiseasesFiscal year 2024 · $4.6MNIH RePORTER 75N93019C00056-P00011-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Antibiotic Resistant BacteriaFiscal year 2024 · $970.6KNIH RePORTER 75N93020C00020-P00009-9999-1 · fetched Nov 12, 2026